Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-25

FDA Approved: SIMVASTATIN — Original Application (XLCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved the original application for SIMVASTATIN from XLCare Pharmaceuticals Inc., granting marketing authorization for a generic simvastatin product. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

ORIG AP for SIMVASTATIN (SIMVASTATIN)